Stevanato Group S.p.A (STVN) Liabilities and Shareholders Equity (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Liabilities and Shareholders Equity of $3.0 billion for Q1 2026, up 23.73% year-over-year from $2.4 billion in Q1 2025, and up 2.15% quarter-over-quarter from $3.0 billion in Q4 2025.
Stevanato Group S.p.A (STVN) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $3.0 billion in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $3.0 billion, up 23.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.5 billion (up 17.88% YoY), and the FY2025 annual result was $3.0 billion, up 19.0% from the prior year.
- Liabilities and Shareholders Equity climbed to $3.0 billion in Q1 2026 per STVN's latest filing, from $3.0 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $3.0 billion in Q1 2026 and troughed at $1.6 billion in Q2 2022.
- A 5-year average of $2.3 billion and a median of $2.4 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- On a YoY basis, Liabilities and Shareholders Equity climbed as much as 35.31% in 2022 and fell as far as 0.38% in 2022.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.7 billion in 2022, then surged by 31.63% to $2.2 billion in 2023, then climbed by 11.65% to $2.5 billion in 2024, then grew by 19.0% to $3.0 billion in 2025, then grew by 2.15% to $3.0 billion in 2026.
- Business Quant data shows STVN's Liabilities and Shareholders Equity at $3.0 billion in Q1 2026, $3.0 billion in Q4 2025, and $2.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | 3.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.02 Bn |
| Dec 31, 2025 | 2.96 Bn |
| Sep 30, 2025 | 2.82 Bn |
| Jun 30, 2025 | 2.66 Bn |
| Mar 31, 2025 | 2.44 Bn |
| Dec 31, 2024 | 2.49 Bn |
| Sep 30, 2024 | 2.43 Bn |
| Jun 30, 2024 | 2.37 Bn |
| Mar 31, 2024 | 2.40 Bn |
| Dec 31, 2023 | 2.23 Bn |
| Sep 30, 2023 | 2.10 Bn |
| Jun 30, 2023 | 1.97 Bn |
| Mar 31, 2023 | 1.87 Bn |
| Dec 31, 2022 | 1.69 Bn |
| Sep 30, 2022 | 1.64 Bn |
| Jun 30, 2022 | 1.64 Bn |
| Mar 31, 2022 | 1.65 Bn |
| Dec 31, 2021 | 1.62 Bn |
| Sep 30, 2021 | 1.64 Bn |
| Jun 30, 2021 | 1.21 Bn |